Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Phase 2
110
about 3 years
18+
1 site in AZ
What this study is about
This trial is testing whether a less aggressive approach to hormone therapy, combined with radiation, can be as effective as standard treatment for prostate cancer. The goal is to determine if reducing the number of hormone treatments (ADT) while still using radiation can provide similar benefits to more intensive ADT regimens in patients whose risk factors suggest they could benefit from a less aggressive strategy.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Receive Gonadotropin-releasing Hormone Analog
- 3.Receive Radiation Therapy
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Antineoplastic Agent [TC] (Cytochrome P450 17A1 Inhibitors), gonadorelin
oral
diagnostic, imaging, radiation